Scientists at UCLA have developed an “off-the-shelf” cell-based immunotherapy that was able to track down and kill pancreatic ...

Novel Platform Aims To Normalize Tumor Acidity, Slow Disease Progression and Extend Survival ...

The Phase II trial follows Amorphical’s preclinical studies, showing the therapy’s capacity to modulate pathological acidity.

In a recent review published in Natures Signal Transduction and Targeted Therapy Journal, a group of authors explored current and future strategies in the design of tumor tissue-, cell-, and organelle ...

Lung cancer is commonly diagnosed as small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC). In America, lung cancer (mainly SCLC and NSCLC) is the second most common cancer among men and ...

Researchers at Washington University School of Medicine in St. Louis, along with collaborators at Northwestern University, ...

Lung cancer is the most diagnosed cancer and the leading cause of cancer death globally, representing an urgent need for new and improved treatment options. Researchers from Brigham and Women’s ...

In a recent article published in Signal Transduction and Targeted Therapy, researchers introduced polymer-based nano-PROteolysis Targeting Chimeras (PROTACs) to address ongoing challenges in targeted ...

A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of ...